PDLI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
PDL BioPharma, Inc.'s cash flow for dividends for the three months ended in Dec. 2013 was $-21.1 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2013 was $-84.0 Mil.
Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.
PDL BioPharma, Inc.'s quarterly payment of dividends declined from Jun. 2013 ($-21.0 Mil) to Sep. 2013 ($-21.0 Mil) but then increased from Sep. 2013 ($-21.0 Mil) to Dec. 2013 ($-21.1 Mil).
PDL BioPharma, Inc.'s annual payment of dividends increased from Dec. 2011 ($-83.8 Mil) to Dec. 2012 ($-83.9 Mil) and increased from Dec. 2012 ($-83.9 Mil) to Dec. 2013 ($-84.0 Mil).
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
PDL BioPharma, Inc. Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2013 was -20.98 (Mar. 2013 ) + -20.984 (Jun. 2013 ) + -20.979 (Sep. 2013 ) + -21.063 (Dec. 2013 ) = $-84.0 Mil.
PDL BioPharma, Inc. Annual Data
PDL BioPharma, Inc. Quarterly Data